Commentary|Podcasts|April 12, 2024
Mitigating Drug Shortages
Author(s)Nicholas Saraceno, Editor
Allen Jacques explains the history behind medications’ lack of supply, while offering ways to help alleviate their impact.
Advertisement
In this exclusive PC Podcast interview, Allen Jacques, a life sciences industry thought leader at Kinaxis, dives into:
- What he sees as limitations of current government efforts when it comes to boosting domestic production of essential medicines, and why they aren’t sufficient
- How and why drug shortages occur
- The challenges that generic drug manufacturers are facing today
- Why more resilient and transparent supply chains are necessary in the pharmaceutical industry, and how these can help mitigate shortage issues
The latest episode of The Pharmaceutical Commerce Podcast is available directly on
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Novartis’ $23 Billion Manufacturing Investment Anchors Industry Shift Toward US Onshoring
2
Trade & Channel Strategies 2025: The $405 Billion Patent Cliff Demands Partnership and Adaptive Market Access Strategies
3
How AI Control Towers and Digital Twins Can Restore Pharmaceutical Profit Margins
4
Why Specialty Drugs Dominate Spending, and the Frontline Roles Shaping Patient Access
5
